financetom
Business
financetom
/
Business
/
International Paper Strikes All-Stock Deal to Purchase UK-Based DS Smith
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
International Paper Strikes All-Stock Deal to Purchase UK-Based DS Smith
Apr 16, 2024 4:03 AM

06:34 AM EDT, 04/16/2024 (MT Newswires) -- International Paper ( IP ) agreed to acquire UK-based packaging peer DS Smith in an all-stock deal with an implied value of about $9.9 billion, to establish a combined global packaging solutions provider.

Under the terms, International Paper ( IP ) will issue 0.1285 of its shares for each share of DS Smith, valuing the firm's stock at 415 pence ($5.16) apiece based on March 25 prices, the companies said in a joint statement Tuesday. The proposed deal will see International Paper ( IP ) shareholders own 66.3% of the combined firm, with DS Smith investors holding the remaining 33.7% stake.

The deal, which requires approval from regulators in the US and Europe, as well as from both companies' stockholders, is anticipated to close by the fourth quarter. International Paper ( IP ) will also seek a secondary listing of its shares on the London stock exchange once the transaction completes.

"Bringing together the capabilities and expertise of both companies will create a winning position in renewable packaging across Europe, while also enhancing IP's North American business," incoming International Paper ( IP ) Chief Executive Andrew Silvernail said in the statement. "I firmly believe this strategic combination offers a unique and highly compelling opportunity to create tremendous shareholder value."

The companies estimate the deal to be accretive to earnings on a per-share basis in the first year after completion, and to generate at least $514 million in annual pretax cash synergies by the end of the fourth year. International Paper ( IP ) expects total costs of about $370 million to attain the synergies.

"The combination with IP is an attractive opportunity to create a truly international sustainable packaging solutions leader that is well positioned in attractive and growing markets across Europe and North America," said DS Smith CEO Miles Roberts. "The combination will enhance our global proposition to customers, create opportunities for colleagues and drive value for shareholders."

Silvernail, who is set to take over the top role at International Paper ( IP ) in the beginning of May, will be CEO of the combined company, while Roberts will remain as a consultant to help out with the integration. The firm will be headquartered in Memphis, Tennessee.

The agreement comes after both firms were reported in late March to be in talks over a potential deal. DS Smith previously agreed in-principal to terms for a 5.14 billion pound takeover by competitor Mondi.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Boeing deliveries drop 27% in June year-on-year
Boeing deliveries drop 27% in June year-on-year
Jul 9, 2024
(Reuters) - Boeing ( BA ) said on Tuesday it delivered more commercial jets in June than in any other month this year, but the total of 44 planes represented a 27% drop on an annual basis amid a whirlwind of legal and production challenges. The company has pledged to expand production by the end of the year, after wrestling...
Sellers of fake Ozempic to face charges in Austrian court
Sellers of fake Ozempic to face charges in Austrian court
Jul 9, 2024
VIENNA, July 9 (Reuters) - Austrian prosecutors said they will bring criminal charges against two men accused of selling fake versions of Novo Nordisk's diabetes drug Ozempic, resulting in bodily harm in three women. The defendants had acted as traders and sold 225 bogus injection pens falsely labelled as Ozempic for 205 euros ($222) apiece to a plastic surgeon in...
Humacyte Signs Licensing Deal With Pluristyx For BioVascular Pancreas Product Development
Humacyte Signs Licensing Deal With Pluristyx For BioVascular Pancreas Product Development
Jul 9, 2024
11:03 AM EDT, 07/09/2024 (MT Newswires) -- Humacyte ( HUMA ) signed an agreement to license Pluristyx's PluriBank induced Pluripotent Stem Cell line as starting materials to manufacture insulin-producing cells for its BioVascular Pancreas product candidate, Pluristyx said Tuesday. BioVascular Pancreas is under development as a potential treatment for type 1 diabetes. Financial terms of the agreement weren't disclosed. Pluristyx...
Middlemen have outsized influence on US drug prices, FTC says
Middlemen have outsized influence on US drug prices, FTC says
Jul 9, 2024
WASHINGTON, July 9 (Reuters) - The consolidation of pharmacies and health insurance companies through years of deal making has led to a handful of pharmacy benefit managers exercising outsized influence over prescription drug prices, the U.S. Federal Trade Commission said on Tuesday. Pharmacy benefit managers, or PBMs, act as middlemen between drug companies and consumers. They negotiate volume discounts and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved